Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 48Unknown 35Recruiting 21Terminated 16Active not recruiting 12Not yet recruiting 8Withdrawn 3No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Multiple Myeloma 1Histologically-confirmed Malignancies 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Positron Emission Tomography Computed Tomography × Clear all
NCT04467281 2022-07-01

A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma

NCT02139150 2019-09-17

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Withdrawn

Histologically-confirmed Malignancies

NCT00451945 2008-06-18

New Indications for Ultrasound in the Staging of Cervical Cancer

Rigshospitalet, Denmark

Phase NA Withdrawn
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡